807639-63-0

Basic information

• Product Name: 1-Pentanol, 5-[[(4-bromo-2-nitrophenyl)methyl]amino]-
• CAS NO: 807639-63-0
• Molecular Formula: C12H17BrN2O3
• Molecular Weight: 317.183
• Mol File: 807639-63-0.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1-Pentanol, 5-[[(4-bromo-2-nitrophenyl)methyl]amino]-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pentanol, 5-[[(4-bromo-2-nitrophenyl)methyl]amino]-(807639-63-0)
• EPA Substance Registry System: 1-Pentanol, 5-[[(4-bromo-2-nitrophenyl)methyl]amino]-(807639-63-0)

Safety Data

• Hazardous Substances Data: 807639-63-0(Hazardous Substances Data)

Upstream product

• 2508-29-4 5-hydroxypentylamine 
• 5551-12-2 4-bromo-2-nitrobenzaldehyde 

Downstream Products

• 807640-15-9 carbamic acid, [[2-[[6-(acetyloxy)-7-methoxy-4-quinazolinyl]amino]-4-bromophenyl]methyl](5-chloroxypentyl)-, phenylmethyl ester 
• 807639-64-1 carbamic acid, [5-(acetyloxy)pentyl][(4-bromo-2-nitrophenyl)methyl]-, 1,1-dimethylethyl ester 
• 890532-74-8 1-pentanol, 5-[[(4-bromo-2-nitrophenyl)methyl]methylamino]-, acetate (ester) 
• 1007591-21-0 carbamic acid, [5-(acetyloxy)pentyl][(2-amino-4-bromo-phenyl)methyl]-, 1,1-dimethylethyl ester 
• 807639-69-6 1-pentanol,5-[[(4-bromo-2-nitrophenyl)methyl]methylamino]- 
• 807640-12-6 carbamic acid, [(4-bromo-2-nitrophenyl)methyl](5-hydroxypentyl)-, phenylmethyl ester 
• 1056010-57-1 carbamic acid, [(4-bromo-2-nitrophenyl)methyl](5-hydroxypentyl)-, 1,1-dimethylethyl ester 

Relevant articles and documents

USE OF A MT KINASE INHIBITOR FOR TREATING OR PREVENTING BRAIN CANCER

-

VEGFR3 INHIBITORS

The present invention relates to the use of some of the macrocyclic quinazoline derivatives described in PCT publication WO2004/105765 as inhibitors of VEGFR3 mediated biological activities, especially those activities which are mediated by VEGFR3 ligands VEGF-C and/or VEGF-D.

3-CYANO-QUINOLINE DERIVATIVES WITH ANTIPROLIFERATIVE ACTIVITY

The present invention concerns the compounds of formula (I) the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof. Compounds of formula (I) inhibit tyrosine kinase enzymes.